Years Ended December 31,
(In thousands except per share amounts)
|
2000
|
1999
|
| |
|
|
| Net Revenue |
$13,262,754
|
$11,881,196
|
 |
| Income from Continuing Operations before Unusual Items* |
2,514,004
|
2,133,257
|
|
| Diluted EPS before Unusual Items |
1.90
|
1.61
|
|
| Loss from Continuing Operations* |
(901,040)
|
(1,207,243)
|
|
| Diluted Loss per Share from Continuing Operations |
(0.69)
|
(0.92)
|
|
| Dividends per Common Share |
0.920
|
0.905
|
|
| Total Assets |
21,092,466
|
23,123,756
|
|
| Stockholders' Equity |
2,818,093
|
6,214,747
|
|
* Unusual items, after-tax, for 2000 were the Warner-Lambert Company termination
fee of $1,111,097, the gain on the sale of Immunex Corporation common stock
of $1,414,859, the diet drug litigation charge of $5,375,000, goodwill impairment
of $341,000, the special charge for the voluntary market withdrawal of any
products containing phenylpropanolamine of $52,000 and the special charge
for certain product discontinuations of $173,000. Unusual items, after-tax,
for 1999 were the diet drug litigation charge of $3,287,500 and the special
charge for the RotaShield voluntary market withdrawal of $53,000.
American Home Products Corporation is a global leader in pharmaceuticals,
consumer health care products and animal health products. Our products are
sold in more than 150 countries, and our product portfolio includes some
of the most innovative therapies introduced in recent years. AHP's worldwide
resources encompass more than 48,000 employees, manufacturing facilities
on five continents and one of the industry's broadest R&D programs, representing
all three major discovery and development platforms - small molecules, proteins
and vaccines.
As one of the world's foremost research-based pharmaceutical companies,
AHP is at the vanguard of the biotechnology revolution that is transforming
the diagnosis, treatment and prevention of disease. We are breaking new
ground in applying biopharmaceutical science to develop novel therapies
for serious, unmet medical needs across a wide variety of therapeutic areas.
|
